Normalisation of tissue factor pathway inhibitor activity after glycaemic control optimisation in type 1 diabetic patients - Rigla,M.; Mateo,J.; Fontcuberta,J.; Souto,J.C.; de Leiva,A.; Pérez,A. (Thromb Haemost, 2000)